Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Transneuronal Degeneration of Thalamic Nuclei following Middle Cerebral Artery Occlusion in Rats.
New oral drugs for the treatment of multiple sclerosis.
Corrigendum to "The-effect-of-triiodothyronine-on-maturation-and-differentiation-of-oligodendrocyte-progenitor-cells-during-remyelination-following-induced-demyelination in male albino rat" [Tissue Cell 48 (March (3)) (2016) 242-251].
Benefits from an autobiographical memory facilitation programme in relapsing-remitting multiple sclerosis patients: a clinical and neuroimaging study.
Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?
Acute Transverse Myelitis and Nicolau Syndrome after Benzathine Penicillin Injection.
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
Exploring the Implications of Small-Area Variation in the Incidence of Multiple Sclerosis.
Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry.
Immunoadsorption in patients with neuromyelitis optica spectrum disorder.
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.
Vitamin D₃ and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
Journal Club: Effect of comorbidity on mortality in multiple sclerosis.
ERβ-Dependent Direct Suppression of Human and Murine Th17 Cells and Treatment of Established Central Nervous System Autoimmunity by a Neurosteroid.
Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
Fatigue and gait speed in multiple sclerosis: Assessment and relationship.
INFLIXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE UVEITIS RESISTANT TO CONVENTIONAL IMMUNOMODULATORY THERAPY.
Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia.
Multiple sclerosis.
Intravenous Immunoglobulins Lower Inflammatory Gene Expression in Skin Biopsies of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
Monooxygenase substrates mimic flavin to catalyze cofactorless oxygenations.
Rasch analysis of the Fatigue Severity Scale in Italian subjects with multiple sclerosis.
Effect of dual-task-induced uncertainty on gait biomechanics in patients with multiple sclerosis with 2-6.5 EDSS grade.
Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
The Incidence of Euphoria in Multiple Sclerosis: Artefact of Measure.
Pages
« first
‹ previous
…
818
819
820
821
822
823
824
825
826
…
next ›
last »